| |
| |
|
| Insider
Information: |
Guy Geoffrey W Dr |
| Relationship: |
Executive Chairman, Di... |
| City: |
Cambridge |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 139.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gw Pharmaceuticals Plc |
GWPH |
Executive Chairman, Di... |
2021-05-05 |
0 |
2021-05-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2021-05-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(128,925) |
0 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2021-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,781,521) |
0 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-12-08 |
4 |
S |
$10.69 |
$2,577,294 |
D/D |
(240,000) |
4,781,521 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-12-07 |
4 |
S |
$10.80 |
$5,282,364 |
D/D |
(480,000) |
5,021,521 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-11-03 |
4 |
AS |
$8.37 |
$2,605,990 |
D/D |
(307,152) |
5,501,521 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-11-03 |
4 |
OE |
$0.00 |
$399 |
D/D |
307,152 |
5,808,673 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-05-29 |
4 |
AS |
$10.24 |
$7,376,400 |
D/D |
(720,000) |
5,501,521 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-03-13 |
4 |
AS |
$6.63 |
$3,978,000 |
D/D |
(600,000) |
6,221,521 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2020-01-15 |
4 |
AS |
$9.42 |
$8,493,000 |
D/D |
(900,000) |
6,821,521 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2019-11-11 |
4 |
S |
$9.33 |
$3,918,600 |
D/D |
(420,000) |
7,721,521 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2019-03-04 |
4 |
S |
$14.75 |
$13,275,000 |
D/D |
(900,000) |
8,141,521 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2019-03-01 |
4 |
S |
$14.49 |
$4,347,000 |
I/I |
(300,000) |
103,925 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2019-03-01 |
4 |
OE |
$0.00 |
$618,509 |
D/D |
576,000 |
9,041,521 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Executive Chairman |
• • – |
2019-03-01 |
4 |
S |
$14.29 |
$8,281,235 |
D/D |
(576,000) |
8,465,521 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
